These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4079040)

  • 1. [Rational dose fractionation schedule 1. Each fractional dose].
    Masuda K; Matsuura K; Miyoshi M; Uehara T
    Gan No Rinsho; 1985 Sep; 31(12):1520-4. PubMed ID: 4079040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dose-time optimization in fractionated radiotherapy].
    Kriester A; Kloetzer KH; Kob D
    Strahlenther Onkol; 1988 Aug; 164(8):489-98. PubMed ID: 3138769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of cell survival after multiple fractions per day and low-dose-rate irradiation of two in vitro cultured rat tumor cell lines.
    van Rongen E
    Radiat Res; 1985 Oct; 104(1):28-46. PubMed ID: 4048393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic radiosensitivity and repair of sublethal radiation-induced damage in canine osteosarcoma cell lines.
    Fitzpatrick CL; Farese JP; Milner RJ; Salute ME; Rajon DA; Morris CG; Bova FJ; Lurie DM; Siemann DW
    Am J Vet Res; 2008 Sep; 69(9):1197-202. PubMed ID: 18764694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy.
    Paganetti H
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):892-900. PubMed ID: 16199319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superfractionation: its rationale and anticipated benefits.
    Douglas BG
    Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1143-53. PubMed ID: 7118617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-rate effects in external beam radiotherapy redux.
    Ling CC; Gerweck LE; Zaider M; Yorke E
    Radiother Oncol; 2010 Jun; 95(3):261-8. PubMed ID: 20363041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repair in normal tissues and the possible relevance to radiotherapy.
    Field SB; Hornsey S
    Strahlentherapie; 1977 Jun; 153(6):371-9. PubMed ID: 877973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery from sublethal damage during intermittent exposures in cultured tumor cells: implications for dose modification in radiosurgery and IMRT.
    Shibamoto Y; Ito M; Sugie C; Ogino H; Hara M
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1484-90. PubMed ID: 15275736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Volume effect models in radiation therapy].
    Sakata S
    Gan No Rinsho; 1987 Oct; 33(13):1532-41. PubMed ID: 3694792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro.
    Wilkins RC; Ng CE; Raaphorst GP
    Radiat Oncol Investig; 1998; 6(5):209-15. PubMed ID: 9822167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-survival curves, alpha/beta ratios, RBE values, and equal effect per fraction for neutron irradiation of jejunal crypt cells.
    Withers HR; Mason KA; Taylor JM; Kim DK; Smathers JB
    Radiat Res; 1993 Jun; 134(3):295-300. PubMed ID: 8316621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCP and NTCP: a basic introduction.
    Baumann M; Petersen C
    Rays; 2005; 30(2):99-104. PubMed ID: 16294901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy dose-fractionation schedules. Hyperfractionation and accelerated treatment regimens.
    Freeman CR; Lehnert S
    Neurol Clin; 1991 May; 9(2):351-62. PubMed ID: 1944104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
    Grégoire V
    Rays; 2005; 30(2):105-8. PubMed ID: 16294902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequellae.
    Koukourakis MI; Yannakakis D
    Anticancer Res; 2001; 21(4B):2973-8. PubMed ID: 11712796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of the optimum dose per fraction from the linear quadratic model.
    Jones B; Tan LT; Dale RG
    Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repair in mouse lung between multiple small doses of X rays.
    Travis EL; Parkins CS; Down JD; Fowler JF; Thames HD
    Radiat Res; 1983 May; 94(2):326-39. PubMed ID: 6856778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.